Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study

被引：2
作者：
Decker, R. H. [1 ]
Gettinger, S. N. [1 ]
Glazer, P. M. [1 ]
Wilson, L. D. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.1074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S574 / S575
页数：2
相关论文
共 50 条
  • [21] Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
    Ampil, Federico L.
    Caldito, Gloria
    [J]. ANNALS OF THORACIC MEDICINE, 2011, 6 (03) : 154 - 156
  • [22] Is the way up the way forward? Radiotherapy dose escalation for non-small cell lung cancer
    Ball, David
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 107 - 108
  • [23] Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study
    Reck, Martin
    Frickhofen, Norbert
    Cedres, Susana
    Gatzemeier, Ulrich
    Heigener, David
    Fuhr, Heinz-Georg
    Thall, Aron
    Lanzalone, Silvana
    Stephenson, Patricia
    Ruiz-Garcia, Ana
    Chao, Richard
    Felip, Enriqueta
    [J]. LUNG CANCER, 2010, 70 (02) : 180 - 187
  • [24] A phase I dose escalation study of sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer (NSCLC)
    Reck, M.
    Frickhofen, N.
    Gatzemeier, U.
    Fuhr, H.
    Lanzalone, S.
    Lechuga, M. J.
    Wang, E.
    Chao, R.
    Felip, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer
    Okamoto, Isamu
    Takeda, Koji
    Daga, Haruko
    Miyazaki, Masaki
    Yonesaka, Kimio
    Kiyota, Hidemi
    Tsurutani, Junji
    Ueda, Shinya
    Ichikawa, Yasuko
    Takeda, Masayuki
    Sekiguchi, Risa
    Tominaga, Kiyomi
    Enatsu, Sotaro
    Nambu, Yoshihiro
    Nakagawa, Kazuhiko
    [J]. LUNG CANCER, 2010, 70 (02) : 168 - 173
  • [26] A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer
    Kouroussis, C
    Agelaki, S
    Mavroudis, D
    Kakolyris, S
    Androulakis, N
    Kalbakis, K
    Souglakos, J
    Mallas, K
    Bozionelou, V
    Pallis, A
    Adamtziki, H
    Georgoulias, V
    [J]. ANTICANCER RESEARCH, 2003, 23 (1B) : 785 - 791
  • [27] Antitumor effects of a novel histone deacetylase inhibitor (chidamide) on non-small cell lung cancer cell lines
    Han, X.
    Zhang, N.
    Yao, J.
    Shi, Y.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S41 - S41
  • [28] Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?
    Hong, Julian C.
    Salama, Joseph K.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 126 - 133
  • [29] Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy
    Panettieri, Vanessa
    Malik, Zafar I.
    Eswar, Chinnamani V.
    Landau, David B.
    Thornton, John M. C.
    Nahum, Alan E.
    Mayles, W. Philip M.
    Fenwick, John D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) : 418 - 424
  • [30] A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer
    Akiyama, Y
    Ohe, Y
    Tamura, T
    Sawada, M
    Inoue, A
    Kusaba, H
    Yamamoto, N
    Sekine, I
    Kunitoh, H
    Kodama, T
    Saijo, N
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (10) : 482 - 487
12345